A carregar...
First-generation versus second-generation long-acting injectable antipsychotic drugs and time to relapse
BACKGROUND: The development of long-acting injectable formulations (LAIs) of second-generation antipsychotic drugs (SGAs) has been suggested as having advantage over first-generation antipsychotic (FGA) LAIs. In this study, we investigated the hypothesis that there was a longer time to relapse in pa...
Na minha lista:
| Publicado no: | Ther Adv Psychopharmacol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6278743/ https://ncbi.nlm.nih.gov/pubmed/30524701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125318795130 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|